Australia seems poised to gain access to a groundbreaking medication for excess weight: Retatrutide. This dual molecule – acting on both GLP-1 and GIP receptors – shows significant outcomes in clinical research, indicating considerable decreases in body fat. While approval hasn't occurred with Au